Novartis in Slovenia has exceptional development opportunities. We can leverage our scale, strengths and expertise in the development and production of innovative medicines.

We support half of Novartis' priority innovative products in various stages of development, production or different services. We participate in all 5 Novartis technology platforms.

Sites and experts in Slovenia contribute significantly to the technological advancements and original approaches that create Novartis high-value medicines for the treatment of patients worldwide. The Ljubljana and Mengeš sites are already key for the technical development, production and marketing of Novartis’ innovative medicines.

We are also very effective in the demanding product transfers from development into production. Both locations, Ljubljana and Mengeš, have in recent years developed to key Novartis innovative medicines launch sites. 

All key Novartis innovative medicines are available for patients in Slovenia.